Silencing information regulator 1 ameliorates lipopolysaccharide-induced acute lung injury in rats via the upregulation of caveolin-1

被引:7
作者
Tong, Fei [1 ]
Shen, Wenchao [2 ]
Zhao, Jingjing [4 ]
Hu, Yonghe [1 ]
Zhao, Qi [6 ]
Lv, Huizhi [5 ]
Liu, Feifan [1 ]
Meng, Zhipeng [1 ]
Liu, Jing [3 ]
机构
[1] Zhejiang Univ, Affiliated Cent Hosp,Huzhou Univ, Huzhou Cent Hosp,Sch Med, Affiliated Huzhou Hosp,Dept Anaesthesiol, 1558 Sanhuan North Rd, Huzhou, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Dept Radiol, Huzhou Tradit Chinese Med Hosp, 315 South St, Huzhou, Zhejiang, Peoples R China
[3] Huzhou Matern & Child Hlth Care Hosp, Dept Anaesthesiol, WuXing Area 2 East St, Huzhou, Zhejiang, Peoples R China
[4] Zhejiang Univ, Affiliated Cent Hosp,Huzhou Univ, Dept Hosp Acquired Infect Control,Affiliated Huzho, Huzhou Cent Hosp,Sch Med, 1558 Sanhuan North Rd, Huzhou, Zhejiang, Peoples R China
[5] Taizhou Sanmen Cty Peoples Hosp, Dept Anaesthesiol, 15 Taihe Rd,Hairun St, Zhejiang, Peoples R China
[6] Huzhou Fourth Hosp, Dept Anaesthesiol, 169 Chengnan Rd, Huzhou, Zhejiang, Peoples R China
关键词
Acute lung injury; Silencing information regulator 1; Signal transducer and activator of transcription; Caveolin-1; lipopolysaccharide; RESPIRATORY-DISTRESS-SYNDROME; SEPSIS; CELLS; ACTIVATION; EXPRESSION; APOPTOSIS; SIRT1; MICE;
D O I
10.1016/j.biopha.2023.115018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Acute lung injury (ALI) is an intractable medical problem linked with to high morbidity and mor-tality all over the worldglobally. The prognosis of advanced acute lung injury remains persistently poor due to its underlying mechanisms remain unclear.Despite advancements in medical research, the its prognosis of advanced ALI remains persistently poor due to unclear underlying mechanisms. We aimed to investigate the protective effects of silencing information regulator 1 (SIRT1) on lipopolysaccharide (LPS)-induced acute lung injuryALI and to reveal its underlying molecular mechanism.Methods: Male Sprague--Dawley rats were divided grouped into 4 groupsfour: normal saline group (group NS), lipopolysaccharide group (group L), SIRT1 activator SRT1720-pretreated group (group S), and SIRT1 inhibitor EX527-pretreated group (group E). Rats They were intranasally dripped with LPS to establish the model of ALI modelsacute lung injury respectively. We investigated the effect of SIRT1 on acute lung injury by analysing We analyzed the CT images of the rat lungs and used, HE staining, lung wet-to-dry ratio, inflammatory factor expression, lung injury marker expression, immunohistochemistry, and related mRNA expression to determine the effect of SIRT1 on ALI. Results: Our results show that LPS induction produced resulted in acute lung injury, ALI and disrupting disrupted normal SIRT1 expression, which led to the overexpression of STAT3, TLR4, TNF-alpha, and IL-6 and suppression of Cav-1 expression. Upregulation The upregulation of Cav-1 protein and mRNA following the administration of an SIRT1 agonist resulted in reduced lung injury. SRT1720 pretreatment was closely associated with reduced ex-pressions of STAT3,TLR4, TNF-alpha, and IL-6. ALI lung injury was more severeworsened after administration of SIRT1 inhibitors, and the changes in the above indicators were reversed.Conclusions: These results suggest that SIRT1 may protect against LPS-induced acute lung injuryALI via by counteracting inflammatory remissionion, and this protective effect might may be mediated by suppressing STAT3 to activate the expression ofinduce Cav-1 expression.
引用
收藏
页数:9
相关论文
共 29 条
  • [1] Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries
    Bellani, Giacomo
    Laffey, John G.
    Pham, Tai
    Fan, Eddy
    Brochard, Laurent
    Esteban, Andres
    Gattinoni, Luciano
    van Haren, Frank
    Larsson, Anders
    McAuley, Daniel F.
    Ranieri, Marco
    Rubenfeld, Gordon
    Thompson, B. Taylor
    Wrigge, Hermann
    Slutsky, Arthur S.
    Pesenti, Antonio
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (08): : 788 - 800
  • [2] Soluble TREM-1 as a predictive factor of neonatal sepsis: a meta-analysis
    Bellos, Ioannis
    Fitrou, Georgia
    Daskalakis, Georgios
    Thomakos, Nikolaos
    Papantoniou, Nikolaos
    Pergialiotis, Vasilios
    [J]. INFLAMMATION RESEARCH, 2018, 67 (07) : 571 - 578
  • [3] Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC
    Chaib, Imane
    Karachaliou, Niki
    Pilotto, Sara
    Codony Servat, Jordi
    Cai, Xueting
    Li, Xuefei
    Drozdowskyj, Ana
    Codony Servat, Carles
    Yang, Jie
    Hu, Chunping
    Felipe Cardona, Andres
    Vivanco, Guillermo Lopez
    Vergnenegre, Alain
    Miguel Sanchez, Jose
    Provencio, Mariano
    de Marinis, Filippo
    Passaro, Antonio
    Carcereny, Enric
    Reguart, Noemi
    Garcia Campelo, Charo
    Teixido, Cristina
    Sperduti, Isabella
    Rodriguez, Sonia
    Lazzari, Chiara
    Verlicchi, Alberto
    de Aguirre, Itziar
    Queralt, Cristina
    Wei, Jia
    Estrada, Roger
    Puig de la Bellacasa, Raimon
    Luis Ramirez, Jose
    Jacobsen, Kirstine
    Ditzel, Henrik J.
    Santarpia, Mariacarmela
    Viteri, Santiago
    Angel Molina, Miguel
    Zhou, Caicun
    Cao, Peng
    Ma, Patrick C.
    Bivona, Trever G.
    Rosell, Rafael
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (09):
  • [4] DFMG attenuates the activation of macrophages induced by co-culture with LPC-injured HUVE-12 cells via the TLR4/MyD88/NF-κB signaling pathway
    Cong, Li
    Yang, Shuting
    Zhang, Yong
    Cao, Jianguo
    Fu, Xiaohua
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (05) : 2619 - 2628
  • [5] METABOLIC DISEASE Exercise hormone fights metabolic disease
    Crunkhorn, Sarah
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (03) : 189 - 189
  • [6] Activation of SIRT1 ameliorates LPS-induced lung injury in mice via decreasing endothelial tight junction permeability
    Fu, Cuiping
    Hao, Shengyu
    Xu, Xiaobo
    Zhou, Jian
    Liu, Zilong
    Lu, Huan
    Wang, Limin
    Jin, Weizhong
    Li, Shanqun
    [J]. ACTA PHARMACOLOGICA SINICA, 2019, 40 (05) : 630 - 641
  • [7] Effect of caveolin-1 on Stat3-ptyr705 levels in breast and lung carcinoma cells
    Geletu, Mulu
    Taha, Zaid
    Arulanandam, Rozanne
    Mohan, Reva
    Assi, Hikmat H.
    Castro, Maria G.
    Nabi, Ivan Robert
    Gunning, Patrick T.
    Raptis, Leda
    [J]. BIOCHEMISTRY AND CELL BIOLOGY, 2019, 97 (05) : 638 - 646
  • [8] Intratracheal instillation of alveolar type II cells enhances recovery from acute lung injury in rats
    Guillamat-Prats, Raquel
    Puig, Ferranda
    Camprubi-Rimblas, Marta
    Herrero, Raquel
    Serrano-Mollar, Anna
    Nieves Gomez, Maria
    Tijero, Jessica
    Matthay, Michael A.
    Blanch, Lluis
    Artigas, Antonio
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (06) : 782 - 791
  • [9] Stem cell therapy for acute respiratory distress syndrome: a promising future?
    Horie, Shahd
    Masterson, Claire
    Devaney, James
    Laffey, John G.
    [J]. CURRENT OPINION IN CRITICAL CARE, 2016, 22 (01) : 14 - 20
  • [10] The SIRT1 inhibitor EX-527 suppresses mTOR activation and alleviates acute lung injury in mice with endotoxiemia
    Huang, Jing
    Tian, Rui
    Yang, Yongqiang
    Jiang, Rong
    Dai, Jie
    Tang, Li
    Zhang, Li
    [J]. INNATE IMMUNITY, 2017, 23 (08) : 678 - 686